iShares Health Innovation Active ETF Rating $24.48 +0.34 (+1.41%) As of 05/2/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsRatingsBuy This Stock iShares Health Innovation Active ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BMED Aggregate RatingModerate Buy 2.76Holdings in BMED have an aggregate rating of Moderate Buy based on 737 analyst ratings issued in the past year covering 42 companies (67.9% of the portfolio).BMED Aggregate Price Target$24.48High Prediction$24.48Average Prediction$24.48Low Prediction$24.48Holdings in BMED have an aggregate price target of $24.48 and a range of $24.48 to $24.48 covering 42 companies (67.9% of the portfolio).BMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy25 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Health Innovation Active ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 42 BMED Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.44%BSXBoston Scientific$104.94+1.7%4.1212 of 5 stars3.04$114.52 9.1%23Positive News3.93%ABTAbbott Laboratories$132.92+1.6%4.9034 of 5 stars2.84$142.59 7.3%19Insider TradePositive News3.76%ARGXargenx$649.67+1.5%2.5193 of 5 stars2.91$699.28 7.6%23Upcoming EarningsPositive NewsGap Up2.80%EWEdwards Lifesciences$75.57+0.5%4.6232 of 5 stars2.42$79.45 5.1%24Short Interest ↓Positive News2.63%CORCencora$292.17+0.6%4.2434 of 5 stars2.78$290.00 -0.7%9Upcoming EarningsPositive News2.62%ABBVAbbVie$198.62+2.7%4.6037 of 5 stars2.89$211.41 6.4%27Positive News2.50%MCKMcKesson$707.28+0.1%4.3926 of 5 stars2.88$681.00 -3.7%16Upcoming EarningsDividend AnnouncementPositive News2.46%GILDGilead Sciences$103.68+0.4%4.8981 of 5 stars2.78$110.55 6.6%27Positive News2.29%MDTMedtronic$84.74+1.4%4.5041 of 5 stars2.44$96.14 13.5%16Positive News2.14%PODDInsulet$257.01+2.7%4.4926 of 5 stars2.76$293.94 14.4%17Upcoming EarningsAnalyst DowngradeNews Coverage1.96%ISRGIntuitive Surgical$529.42+2.4%4.6862 of 5 stars2.75$598.95 13.1%20Positive News1.95%BMYBristol-Myers Squibb$50.56+1.9%4.7033 of 5 stars2.32$58.00 14.7%221.88%RGENRepligen$141.51+3.1%4.6268 of 5 stars2.64$173.25 22.4%14Earnings ReportAnalyst RevisionPositive News1.75%NTRANatera$156.66+3.5%2.861 of 5 stars3.00$175.76 12.2%16Upcoming EarningsInsider TradeNews CoveragePositive News1.61%EXELExelixis$39.60+1.8%3.9697 of 5 stars2.47$37.59 -5.1%19Short Interest ↑Positive News1.59%AMGNAmgen$281.22-0.9%4.0825 of 5 stars2.41$308.18 9.6%22Earnings ReportAnalyst ForecastAnalyst RevisionPositive NewsGap Up1.55%JNJJohnson & Johnson$156.09+1.1%4.7182 of 5 stars2.63$171.82 10.1%19Analyst RevisionPositive News1.46%RYTMRhythm Pharmaceuticals$64.01+0.3%3.7591 of 5 stars3.00$74.92 17.0%13Upcoming EarningsPositive News1.45%HALOHalozyme Therapeutics$61.19+1.9%4.1093 of 5 stars2.60$62.89 2.8%10Upcoming EarningsAnalyst RevisionNews Coverage1.43%ONCBeigene$255.77+0.1%1.7249 of 5 stars3.00$318.88 24.7%6Analyst RevisionNews Coverage1.43%EXASExact Sciences$51.55+9.3%4.5006 of 5 stars2.95$70.90 37.5%22Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap UpHigh Trading Volume1.38%GHGuardant Health$46.85-4.1%4.4441 of 5 stars3.05$51.64 10.2%22Earnings ReportGap UpHigh Trading Volume1.30%NBIXNeurocrine Biosciences$109.68+2.9%4.884 of 5 stars2.86$160.90 46.7%221.25%ALNYAlnylam Pharmaceuticals$259.39+1.7%4.0953 of 5 stars2.77$319.17 23.0%26Earnings ReportAnalyst DowngradeNews Coverage1.20%TECHBio-Techne$50.49+1.7%4.8862 of 5 stars2.38$81.14 60.7%8Upcoming EarningsPositive NewsGap Up1.17%PENPenumbra$295.97+1.4%4.2015 of 5 stars2.88$302.40 2.2%17Positive NewsGap Up1.16%HOLXHologic$54.16-5.4%4.8335 of 5 stars2.41$81.15 49.8%17Earnings ReportAnalyst ForecastGap DownHigh Trading Volume1.11%MRUSMerus$44.19-2.8%3.3792 of 5 stars3.13$85.31 93.0%16Upcoming EarningsShort Interest ↓1.03%WSTWest Pharmaceutical Services$211.27+0.5%4.6558 of 5 stars3.00$332.50 57.4%80.98%PFEPfizer$24.19+1.1%4.9807 of 5 stars2.53$29.17 20.6%15Earnings ReportAnalyst Revision0.97%DHRDanaher$199.15+1.2%4.9413 of 5 stars2.80$264.40 32.8%20Short Interest ↑0.96%TMOThermo Fisher Scientific$423.69+0.9%4.9093 of 5 stars2.81$607.43 43.4%21Short Interest ↑Positive NewsGap Up0.91%LHLaboratory Co. of America$247.89+2.7%4.4409 of 5 stars2.87$267.85 8.1%15Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews CoveragePositive News0.85%INSMInsmed$72.30-0.5%4.3688 of 5 stars3.00$94.00 30.0%16Upcoming EarningsInsider TradeNews CoveragePositive News0.81%SYKStryker$378.60+1.2%4.791 of 5 stars2.79$426.53 12.7%19Earnings ReportAnalyst ForecastAnalyst RevisionPositive NewsHigh Trading Volume0.78%UTHRUnited Therapeutics$294.60+0.3%4.9881 of 5 stars2.67$392.00 33.1%12Earnings ReportAnalyst DowngradeInsider TradePositive News0.75%BDXBecton, Dickinson and Company$168.61-0.5%4.9435 of 5 stars2.40$235.88 39.9%10Earnings ReportDividend AnnouncementAnalyst ForecastHigh Trading Volume0.75%ALCAlcon$98.39+2.3%2.0818 of 5 stars2.71$106.22 8.0%14Short Interest ↑Gap Up0.75%PTCTPTC Therapeutics$49.95+0.9%3.8974 of 5 stars2.53$63.92 28.0%15Upcoming EarningsAnalyst RevisionNews CoveragePositive News0.74%DGXQuest Diagnostics$177.96+0.4%4.6482 of 5 stars2.69$185.07 4.0%16Short Interest ↑Positive News0.72%BIIBBiogen$123.53+2.2%4.6959 of 5 stars2.38$195.85 58.5%32Earnings ReportAnalyst ForecastAnalyst Revision0.68%BBIOBridgeBio Pharma$38.57+0.4%4.6134 of 5 stars2.92$57.09 48.0%12Earnings ReportAnalyst Revision This page (NYSEARCA:BMED) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Health Innovation Active ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Health Innovation Active ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BMED Stock Free BMED Stock Alerts